DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Haude M, Ince H, Abizaid A. et al.
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.
Eur Heart J 2016;
37: 2701-2709
We do not assume any responsibility for the contents of the web pages of other providers.